Large randomised clinical trials in other (non-vascular) conditions

Hamid Band

Tyrosine Kinase Regulation Via Protein Degradation

Leukaemia

Hematology and hematologic malignancies Pathology

Catherine Ju-Ying Wu

(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL

Leukaemia

Hematology and hematologic malignancies Pathology

Henry Ddungu

The Optimal Use of Platelet Support Transfusion Among Patients with Hematological Malignancies in Uganda

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Dean W Felsher

Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death

Sarcoma Liver and intrahepatic bile ducts Leukaemia

Investigator from University of Helsinki

Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells

Leukaemia

David A Scheinberg

Mechanisms of action of a TCR-like antibody to WT1

Leukaemia

Alex Kentsis

Aberrant activation of HGF/MET signaling as a therapeutic target in AML

Leukaemia

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Hematology and hematologic malignancies Pathology

Javier Adachi

Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru

Leukaemia

Hematology and hematologic malignancies Pathology